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ABSTRACT
Fever is the leading cause of paediatric outpatient consultations in Sub-Saharan Africa. Although most are suspected to be
of viral origin, a putative causative pathogen is not identiﬁed in over a quarter of these febrile episodes. Using a de novo
assembly sequencing approach, we report the detection (15.4%) of dicistroviruses (DicV) RNA in sera collected from 692
febrile Tanzanian children. In contrast, DicV RNA was only detected in 1/77 (1.3%) plasma samples from febrile Tanzanian
adults, suggesting that children could represent the primary susceptible population. Estimated viral load by speciﬁc
quantitative real-time RT–PCR assay ranged from < 1.32E3 to 1.44E7 viral RNA copies/mL serum. Three DicV full-length
genomes were obtained, and a phylogenetic analyse on the capsid region showed the presence of two clusters
representing tentative novel genus. Although DicV-positive cases were detected throughout the year, a signiﬁcantly
higher positivity rate was observed during the rainy season.
This study reveals that novel DicV RNA is frequently detected in the blood of Tanzanian children, paving the way for
further investigations to determine if DicV possibly represent a new agent in humans.
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Introduction
Infectious febrile illnesses are leading causes of paedia-
tric outpatient consultations in Sub-Saharan Africa.
For a large proportion of these cases, the microbial
aetiology remains unknown even after extensive diag-
nostic panels have been applied; thus, it is suspected
that new or divergent viruses that are not detectable
by standard targeted diagnostics assay may be involved.
High-throughput sequencing (HTS) coupled with de
novo assembly oﬀers the possibility of recognizing
viral RNA or DNA in an unbiased fashion. HTS-
based screenings in both vertebrate and non-vertebrate
biological specimens [1–3] have shown that the diver-
sity of viruses circulating in the animal world is larger
than anticipated (including potential human infections
such as astroviruses, reoviruses, pseudorabies viruses,
and bornaviruses [4–9]), and that many viral families
are shared by the two kingdoms, raising the possibility
of yet to be discovered viral infections in humans [10].
Using HTS and a de novo assembly approach, we
screened sera collected from febrile Tanzanian children
for the presence of unrecognized viral agents. These chil-
dren were enrolled in a large cohort investigating the
clinical impact of point-of-care patient management
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system featuring an electronic algorithm based on host
biomarkers [11]. After identifying an index case har-
bouring a full-length sequence of dicistrovirus (DicV),
we used the complete original sequence obtained to
extend screening across the 692 paediatric patients
enrolled in this cohort, as well as 77 febrile adults
included in a similar study [12]. Dicistroviridae are
non-enveloped, positive-sense single-stranded RNA
viruses belonging to the picorna-like viruses. DicV infect
a wide spectrum of arthropods including species that are
known to feed on human blood [13].
This report describes the detection of DicV RNA,
including full-length genomes, in sera from Tanzanian
children with acute febrile illnesses. The presence of
DicV RNAwas further conﬁrmed by speciﬁc quantitative
real-time RT–PCR assays as well as conventional sequen-
cing. We also provide a description of epidemiological,
demographic and clinical features associated with the
presence of DicV sequences and propose strategies for
further investigations to explore the role of this virus.
Materials and Methods
Study design
A total of 692 serum samples were selected from a larger
paediatric cohort of 3192 patients (2 months to 5 years
of age). Participants were consecutively recruited
between December 2014 to February 2016 across nine
outpatient clinics in Dar es Salaam (Tanzania) accord-
ing to the inclusion criteria of “acute febrile illness” [11].
The 692 serum samples were randomized from a sub-
cohort of patients with the diagnoses of “fever without
source”, “severe febrile illness” or “malaria” as detected
by PCR (Figure 1). This sub-cohort represents a group
of particular clinical interest for expanded diagnostic
screening. As sample randomization in children was
limited by sample volume availability, we analysed the
selection for potential bias. Selected samples were not
signiﬁcantly diﬀerent for all key demographic variables
(such as age and sex) nor for geographic (district) or
temporal (season) features. In addition, 77 plasma
specimens were randomly selected from an adult cohort
of 519 patients. Adult patients were consecutively
recruited between July 2013 to May 2014 across outpa-
tient clinics in Dar es Salaam according to the inclusion
criteria of “acute febrile illness” [12]. Samples were then
randomly selected from a sub-cohort of interest with
the same 3 diagnoses as above (Figure 1).
Ethical approval
This study has received local IRB approval in Tanzania
by the Ifakara Health Institute and the National Institute
for Medical research (paediatric cohort: IHI/IRB/EXT/
16-2015 and NIMR/HQ/R.8a/Vol. IX/1789; adult
cohort: IHI/IRB/No: 12–2013 and NIMR/HQ/R.8a/
Vol. IX/1561). IRB approval was also granted for ana-
lyses undertaken in Switzerland by the Ethikkommission
Nordwest- und Zentralschweiz (paediatric cohort:
EKNZ UBE-15/03 and adult cohort: EK 1612/13).
De novo analysis and sequence analysis
Unbiased HTS protocols was performed on the 692
sera and 77 plasma specimens from the paediatric
and adult cohorts, respectively. Using a de novo assem-
bly approach (see below), an index case harbouring a
full-length sequence of DicV was detected. This com-
plete DicV sequence was used to extend screening
across all specimens analysed by HTS.
The sample preparation for HTS analysis (i.e. speci-
men centrifugation, DNAse treatment and RNA
extraction by TRIzol) was performed as previously
published [14]. RNA libraries (TruSeq total RNA prep-
aration protocol (Illumina, San Diego, US)) were mul-
tiplexed by 4 and run on a HiSeq 2500 (Illumina, San
Diego, CA, USA). Raw data were low-quality and
adaptor-trimmed using Trimmomatic (V0.33),
human- sequence subtracted (GRCh38, gencode.V23)
using snap-aligner (v1.0beta.23) and then analysed
using the de novo genome assembly IDBA-UD soft-
ware (v.1.1.3) [15]. Reads from raw data were mapped
to complete-coding genomes obtained in previous
steps. Cross-lane contamination was checked using a
crosstalk rate of 0.3% [16]. Cross-lane contamination
was detected for 22 paediatric samples which were sub-
sequently excluded. The remaining 670 samples from
individual patients were retained for further epidemio-
logic, demographic and clinical investigations (Table 1).
The median of total number of read pairs obtained
were 45’386’721 and 46’177’840 for DicV- and DicV+
patients, respectively, with a minimum of 15’760’060
read pairs obtained for DicV+ patients.
To check potential reagent contaminants, 38 nega-
tive controls (DNase-free, RNase-free H2O) submitted
to the whole HTS process were tested by de novo
analysis (Figure 1).
After removal of PCR duplicates, only sequences with
a coverage≥ 5x for each individual nucleotide were con-
sidered for further analysis (Figure 2a-c). Three com-
plete coding sequences were obtained and submitted
to GenBank (accession no. MH536109-11). Phyloge-
netic trees were inferred for the RNA-dependent RNA
polymerase (RdRp) (Figure 2b) and the capsid regions
(Figure 2c) using a 500-replicate Maximum Likelihood
method based on the LGmodel [17]. Analyses were per-
formed with a Gamma distributed rate model with
invariant sites using MEGA X software [18].
Speciﬁc dicistrovirus real-Time RT–PCR
The aligned DicV sequences obtained from de novo
analysis were used to design two speciﬁc real-time
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RT–PCR assays (Table 2): the quantitative DicV-Cap-
sid and the semi-quantitative DicV-ORF1/RdRp.
Samples in which DicV was identiﬁed by HTS analysis
and for which suﬃcient volume remained (n = 38/103)
were checked by these real-time RT–PCR assays.
Brieﬂy, the viral genomes were extracted using the
NucliSENS easyMAG (bioMérieux, Geneva, Switzer-
land) nucleic acid kit from 190 ul of sera spiked with
10 ul of standardized canine distemper viruses, as pre-
viously described [19]. Nucleic acids were eluted in 25
ul and then screened for the presence of DicV using the
DicV-Capsid real-time quantitative assay (upper and
lower limits of quantiﬁcation are 1.32E8 and 1.32E3
estimated viral RNA copies/mL, respectively) and the
DicV-ORF1/RdRp assay. Both assays were performed
using the one-step QuantiTect Probe RT–PCR Kit
(Qiagen, Hombrechtikon, Switzerland) in a StepOne
Plus instrument (Applied Biosystems, Rotkreuz, Swit-
zerland) under the following cycling conditions: 50°C
for 30 min, 95°C for 15 min, 45 cycles of 15 s at 94°
C, and 1 min at 55°C.
Additional Tanzanian cohort screened for DicV
by real-Time RT–PCR
The study was designed to assess the role of rickettsial
infection as a source of fever amongst paediatric and
adult outpatients in North-Eastern Tanzania. The
study was based at the National Institute for Medical
Research’s (NIMR) ﬁeld station in Korogwe, Tanga
Region. The ﬁeld station is associated with Korogwe
District Hospital (KDH).
Between 1 December 2017 and 30 April 2018,
patients of ﬁve years and above presenting to the Out-
patient Department of KDH with fever (>37.5°C tym-
panic) or a reported history of fever within the last
three days were recruited. Blood was taken on day 0
and day 28 to establish a serological diagnosis of
acute rickettsial infection. Amongst 336 patients
recruited for the study, 271 (81%) completed the follow
up on day 28. Amongst those patients with paired sera
available (at least 500 μl per serum), 100 individuals
(range from 6 to 80 years of age, median age = 27
years) were randomly selected for DicV screening by
the DicV-Capsid and the DicV-ORF1/RdRp real-time
RT–PCR assays. Among the 100 screened patients, 60
were > 16 years of age (median age = 45 years of age)
and 40 were between 6 and≤ 16 years of age (median
age = 10 years of age). The study was approved by the
National Ethics Review Committee of the National
Institute for Medical Research, Tanzania.
Respiratory and dicistrovirus detection in
respiratory specimens
Of the 21 paediatric patients with respiratory symp-
toms (Table 1) a nasopharyngeal swab specimen
(NPS) was collected for 16 subjects (3 DicV+ and 13
Figure 1. Study ﬂow chart. Severe febrile illness is deﬁned as having severe tachypnea (respiratory rate ≥97th percentile for age
and temperature), severe tachycardia (heart rate ≥90th percentile for age and temperature), Hypoxemia (SaO2 < 90%), inability to
tolerate oral ﬂuids and/or neurological danger signs (such as coma or >2 convulsions in 24 h). The diagnosis of “fever without
source” is attributed when the probable cause of a febrile illness cannot be determined by history or physical examination. The
diagnosis of “malaria” is attributed in case of positive malaria-speciﬁc quantitative PCR, targeting multiple genomic copies of
the conserved C-terminus of the var gene family (detection level: 0.1 parasite/µl). HTS: high-throughput sequencing, DicV: dicis-
trovirus, RT-PCR: reverse transcription PCR.
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Table 1. Comparative analysis between dicistrovirus-positive and negative febrile children.
* p < 0.05, CRP: C-reactive protein, PCT: procalcitonin, HIV: human immunodeﬁciency virus
† 36 cases with an unknown district excluded
‡ data on this symptom was only collected from children old enough to express the symptom/respond to the question
§ data limited by sample availability (only collected when clinically appropriate or insuﬃcient sample volume)
# PCT is an inﬂammatory marker, values larger than 0.5ug/ml have been associated to a higher risk of bacterial infection
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DicV- by HTS). The 16 NPS were extracted using the
NucliSENS easyMAG (bioMérieux) and screened for
the presence of DicV (using the DicV-Capsid and the
DicV-ORF1/RdRp real-time RT–PCR assays) and a
large panel of respiratory viruses using the FTD® Res-
piratory pathogens 21 commercial kit (Fast Track
Diagnostics, Sliema, Malta).
Statistical analysis
Statistical analysis compared various demographic
(age, sex), epidemiological (seasonality, location) and
clinical (signs, symptoms, co-morbidities and out-
comes) parameters between the HTS DicV- (n = 567)
and DicV+ (n = 103) paediatric sera samples. Analyses
were undertaken using Stata (StataCorp. 2015, College
Station, TX, USA) and associations between the vari-
ables of interest and the presence of DicV sequences
were assessed using chi-squared, Spearman correlation
and Kruskel-Wallis tests, as appropriate. Results are
presented as means with 95% conﬁdence intervals, fre-
quencies and percentages. A two-sided P-value of <0.05
was considered statistically signiﬁcant.
Results
Dicistrovirus identiﬁcation and screening
Of the 670 sera (from 670 individual paediatric sub-
jects), DicV genome sequences were detected in 103
samples (15.4%) (Figure 1; total number of DicV map-
ping reads ranging from 2 to 121’610, mean = 3’379,
median = 240). To conﬁrm the HTS analysis ﬁndings,
all positive sera with suﬃcient leftover volume (n =
38) were assessed with the quantitative DicV-Capsid
and the DicV-ORF1/RdRp real-time RT–PCR assays.
Thirty/38 (79%) sera were conﬁrmed DicV+ by real-
time RT–PCR (21/30 by the two assays, 9/30 by one
assay). The corresponding numbers of DicV-speciﬁc
reads ranged from 6 to 121’610 for real-time RT–
PCR positive sera. Estimated viral load ranged from
< 1.32E3 up to 1.44E7 viral RNA copies/mL of sera
(median viral load = 5.67E3 viral RNA copies/mL).
The 8 sera not conﬁrmed by real-time RT-PCRs
had≤ 280 DicV-speciﬁc reads (median = 16 reads)
obtained by the HTS analysis. Of these 8 sera, 7 had
a suﬃcient initial volume for further testing and
prepared in two dilutions (1:2 and 1:10) to remove
potential PCR inhibitors. None was found positive by
real-time RT–PCR. In parallel, 80 sera found DicV-
negative by HTS analysis were randomly selected
throughout the entire recruitment period of 2015 and
assessed by the DicV-Capsid and DicV-ORF1/RdRp
real-time RT–PCR assays; 5 were found positive (4
sera collected in February and 1 in July; viral load ran-
ged from < 1.32E3 to 2.11E4 viral RNA copies/mL of
sera) suggesting that the DicV prevalence of 15.4%
observed by HTS represents a minimal estimate.
In contrast to the HTS analysis results obtained with
the paediatric cohort, the presence of DicV RNA was
detected in only one of 77 (1.3%) plasma specimens
from the adult cohort (2 reads, real-time RT-PCRs
were performed but the results were not conclusive
due to the presence of a very strong PCR inhibition)
(Figure 1). In parallel, the 76 plasma found DicV-nega-
tive by HTS analysis were assessed by the DicV-Capsid
and DicV-ORF1/RdRp real-time RT–PCR assays; 1 was
found positive (collected in November 2013; viral load
was < 1.32E3 viral RNA copies/mL of plasma). Of
note, among the 38 negative controls submitted to the
whole HTS process, none was found positive for DicV.
Dicistrovirus sequence analysis
The phylogenetic trees based on the RdRp and the cap-
sid regions (Figure 2b,c) show that the Tanzanian DicV
sequences share the closest amino acid identities with
the Hubei picorna-like virus 22 (NC_033227.1) for
RdRp (53% identity) and capsid (32% identity)
proteins. Based on the divergence of sequences in the
capsid region, the three Tanzania sequences
(MH536109-11) indicated the presence of two clusters
representing tentative novel genus (Figure 2c). Indeed,
in the capsid region, an amino acid identity of 95.2% is
observed between the two clusters, while an amino acid
identity of 99.46% is present in the RdRp region.
Demographic and epidemiological analysis
A comparative analysis of demographic and clinical
features between the DicV+ and DicV- paediatric
populations are listed in Table 1. While there was a
similar sex ratio between DicV+ and DicV- groups
(61% vs 55%, p = 0.25), DicV+ patients had a lower
mean age compared to the DicV- group (16.4 vs 18.9
months, p = 0.02).
A monthly distribution analysis shows signiﬁcantly
higher prevalence of positive cases during the wet sea-
son (minor rain period) than during the dry season (p
< 0.001, Table 1). Indeed, 45.6% of DicV infections
occurred in the minor rain period (47/103, Figure 3).
Signiﬁcant geographic clustering occurred across
three districts in Dar es Salaam (p > 0.001). Whilst
the Kinondoni and Temeke districts had a 12 and
13% DicV prevalence, respectively (51/417 and 20/
151, respectively), infections were 3-fold more frequent
in the Ilala district (39%, 26/66).
Clinical analysis
Overall, DicV presence did not vary signiﬁcantly
among the 3 major sub-cohorts of fever without source
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Table 2. Primer and probe sequences. Fwd: primer forward, Rev: primer reverse, AT: PCR annealing temperature, NT: nucleotide.
Assay Sequence (5’ to 3’)
Final [uM] Fwd/Rev/
Probe
Real-time RT-PCR DicV-Capsid Fwd GGGATGCAYGCTCTTGTAAATT 0.9/0.9/0.25
Rev CRCACACCAACGAAACCA
Probe FAM - ATGTCAGGCATTGAAC – MGBNFQ
DicV-ORF1/RdRp Fwd AGCTGGCGATTTCTCAAATTATG 0.9/0.9/0.25
Rev TCGTCGTAAAATTCGTTGATTATGTC
Probe FAM - TGGTACATTGCATCCCGAYATCTTATTGG -TAMRA
Target region Sequence (5’ to 3’)
Product
size (nt) AT (°C)
Classic RT-PCR ORF1 Fwd1 TGAAGATTTCGAAGGAAAAATGG 427 50
Rev1 ACGCGTTCTATTTATTCCTCGA
Fwd2 ATGATTCCAATACCGGATGTTGAGA 380 50
Rev2 ATTCCTCGAATAAATTGTGAACACG
Figure 2. Analysis of Dicistrovirus sequences. (a) Location of DicV sequences with more than ﬁfty percent DicV genome coverage
obtained by de novo analysis for positive subjects. A schematic representation of the major ORFs of the DicV genome is featured at
the top of the ﬁgure (Hel: helicase domain [pfam00910]; RdRp: RNA-dependent RNA polymerase domain [pfam00680]; Capsid
domains include two Picornavirus capsid-like domains [cd00205], a DicV VP4 domain and CRPV capsid protein like domain
[pfam08762]). On the right side is indicated when the presence of DicV could be veriﬁed by real-time RT-PCR (*) in sera with
suﬃcient leftover volume and/or by RT-PCR followed by classical sequencing (▴). (b) Phylogenetic tree of the RdRp region of
DicV. The 370-residue amino acid sequence considered for RdRp alignment is between position 1435 and 1804 of ORF1. Dicistro-
virus sequences found in human blood are in bold font; the three complete coding sequences obtained in this study (TANZANIA 1–
3), the Human blood-associated dicistrovirus sequence reported from a Peruvian patients with fever of unknown aetiology [21], and
the KENYA sequence detected by our retrospective analysis in one pool (SRR4255933) from a study that investigated the plasma
virome of febrile adult Kenyans [22]. (c) Phylogenetic tree of the capsid region of DicV. The 791-residue amino acid sequence con-
sidered for capsid alignment is between position 73 and the terminus of ORF2. Dicistrovirus sequences found in human blood are in
bold font; the three complete coding sequences obtained in this study (TANZANIA 1–3), and the Human blood-associated dicis-
trovirus sequence reported from a Peruvian patients with fever of unknown aetiology [21].
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(16%), malaria (18%) and severe febrile illness (15%)
(Figure 1).
Clinical features such as axillary temperature,
cough, respiratory distress, vomiting, diarrhoea, dys-
uria, any ear or eye problems, dermatological symp-
toms, and clinical danger signs were not signiﬁcantly
diﬀerent between DicV+ and DicV- paediatric patients
(Table 1). The presence of DicV was not associated
with other concomitant infections such as malaria,
HIV or urinary tract infections, nor was it signiﬁcantly
diﬀerent in patients with common co-morbidities such
as malnutrition, anaemia or sickle cell disease. Out-
comes and severity measures were also not aﬀected.
While the inﬂammatory marker C-reactive protein
(CRP) was not signiﬁcantly diﬀerent among the
groups, procalcitonin (PCT) was signiﬁcantly higher
in the presence of DicV (9ug/ml vs 4.9ug/ml, p =
0.04), where a level of >0.5ug/L was 18% more frequent
in DicV+ patients (p = 0.01).
The temporal distribution of diseases representing
the major modes of infectious transmission was com-
pared to DicV prevalence (Figure 4). The analysis
revealed a temporal symmetry between the predicted
probabilities of DicV infection and respiratory disease,
which both peaked during the wet season. This is in
contrast to both mosquito-vectored disease (malaria)
and diseases usually transmitted via the fecal-oral
route (diarrheal diseases) which peak in the post-
ﬂood and dry season. A total of 21 paediatric patients
presented with respiratory distress (Table 1). For 16
subjects (13 DicV- and 3 DicV+ by HTS) a nasophar-
yngeal swab (NPS) sample was collected and screened
by real-time (RT-)PCR for DicV and a large panel of
respiratory viruses. Of the 13 DicV- patients, 11 were
found positive for a respiratory virus in their respective
NPS samples (three human parainﬂuenza virus type 3,
three human rhinovirus, two human parainﬂuenza
virus type 2, two human coronavirus HKU1 and one
human parechovirus; no viral co-infections were
observed). Of the three DicV+ patients, one respiratory
virus was detected (human rhinovirus). Regarding
DicV screening, none of the 13 DicV- patients had
DicV sequences detectable in their NPS samples. In
contrast, one NPS of the three available from the
DicV+ patients was also found positive for DicV
sequences (low viral load, no viral co-infection
observed). This patient had DicV sequences detectable
in serum by HTS which was conﬁrmed by speciﬁc real-
time RT–PCR assay (with an estimated viral load of
1.2E5 viral RNA copies/mL of serum).
Discussion
Using an unbiased HTS approach and de novo assem-
bly analysis, we identiﬁed distinct novel DicV
sequences in 15.4% of paediatric patients attending
an outpatient clinics for a febrile illness. Most DicV+
sera contained a large number of reads and a signiﬁcant
proportion of the DicV genomes was thus frequently
obtained (Figure 2a), including full-length genomes
in 3 cases. These HTS-based ﬁndings were sub-
sequently veriﬁed by two speciﬁc in-house real-time
RT–PCR assays in the 38 samples which had suﬃcient
leftover sera (Figure 1) and by conventional sequencing
in 5 samples selected for their high viral load (100%
nucleotide identity, data not shown). Positivity in 30
of 38 (79%) cases could be conﬁrmed by real-time
RT–PCR with a median of 5.7E3 viral RNA copies/
mL of sera and, in some cases, reached up to 1xE7
viral RNA copies/mL, supporting a signiﬁcant viral
load. In contrast to children, only one of 77 adults
was found to be DicV-positive by HTS from a parallel
cohort, suggesting that children could represent the
predominant susceptible population. However, this lat-
ter observation should be interpreted with caution
since a potential temporal bias cannot be ruled out
(sampling times for the paediatric and adult cohorts
are not overlapping). In order to expand our screening
we tested by real-time RT–PCR 100 paired sera from
adult and paediatric patients enrolled in a North-East-
ern Tanzania cohort (Tanga region) between Decem-
ber 2017 and end of April 2018; we did not identify
any DicV positive cases. However, not only a restricted
number of adult (n = 60) and paediatric (n = 40) cases
could be tested in this later cohort but also the paedia-
tric populations studied in the Tanga and Dar es Sal-
aam cohorts are diﬀerent (e.g. age of enrolment) and
limit our conclusions.
We also observed a clear seasonal distribution with
clustering in the minor rain period of the wet season
while few cases observed during the dry season (Figure
3). Taken together, these observations point toward the
potential identiﬁcation of a previously uncharacterized
viral agent in human blood. This represents only a ﬁrst
step since we could unfortunately not have access to
follow-up samples or any other validation cohort.
According to Lipkin proposal concerning the levels of
certainty in pathogen discovery, our ﬁnding fulﬁl the
Level 1 criteria [20].
Whatever the molecular technology used, the dis-
covery of new viral genomic sequences in body ﬂuids
must ﬁrst exclude the possibility of contamination
and/or spurious bioinformatics results particularly
when HTS is used. In the present study, contamination
has been carefully considered and is considered unli-
kely for the following reasons: Firstly, none of the 38
HTS negative controls that followed the entire HTS
procedure revealed any DicV sequences, excluding
the possibility of reagent contamination. Secondly,
DicV positivity by HTS analysis was successfully
cross-validated by separate extraction and real-time
RT–PCR assays in 30/38 DicV+ patient sera with
suﬃcient leftover volume, excluding the probability
of spurious bioinformatics results and further
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eliminating contamination of HTS reagents (especially
considering the absence of any common reagent
between the HTS and real-time RT–PCR protocols).
Five sera with the highest number of DicV reads
were conﬁrmed by conventional RT–PCR sequencing
(Figure 2a; Table 2). The viral loads detected by real-
time RT–PCR corresponded in most cases to the
HTS read coverage and ranged from < 1.32E3 up to
1xE7 viral RNA copies/mL; this viral load heterogen-
eity speaks against a common and systematic source
of contamination and would rather be compatible
with the expected kinetics of an acute viral infection.
The sequence heterogeneity (amino acids identity is
97.8% between the 3 DicV full-length sequences
MH536109-11) found across DicV+ samples indicate
diﬀerent origins and speaks against a unique viral
RNA source or spurious bioinformatics ﬁndings.
Additionally, a phylogenetic analyse on the capsid
region show the presence of two DicV clusters
(amino acid identity was 95.2%) without any evidence
of co-detections. Although only observed in a single
case in blood samples, the presence of the DicV gen-
ome was previously reported in a Peruvian cohort of
patients with fever of unknown aetiology [21]. In
Figure 4: Temporal distribution of diseases representing the major modes of infectious transmission (airborne, fecal-oral and mos-
quito-borne) compared to DicV prevalence. The mean predicted prevalences (fractional polynomial trendlines) and their 95% conﬁ-
dence intervals (shaded areas around trendlines) are depicted for the probability of having the diagnoses of 1: “Respiratory
infection” (dashed black line), 2: “Diarrheal disease” (white dashed line) and 3: Malaria (white solid line). The predicted prevalence
of DicV is shown as a solid black line. The months of the entire 2015 recruitment period are depicted. Seasons are indicated below.
DicV: Dicistrovirus.
Figure 3. Monthly Dicistrovirus-positivity rate in febrile children. Bar graphs represent the positivity rates (%) (Left Y axis) of DicV
RNA across each month of the study. Too few specimens (n = 10) were collected in December 2014 and February 2016 to provide
reliable positivity rates, and, thus, are not represented on the graph. The total number of sera collected appear in the base of each
bar. A dotted line with shaded CI95% shows a fractional polynomial trendline for predicted DicV positivity (also featured on the left
Y axis). The rainfall recorded in Dar es Salaam (mm; adapted from https://www.worldweatheronline.com/dar-es-salaam-
weatheraverages/dar-es-salaam/tz.aspx) over the patient recruitment period appears as a shaded graphic in the background
(Right Y axis). Corresponding seasons are indicated below.
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comparison to the Tanzanian sequences, the Peruvian
DicV viral sequence showed amino acid identities as
low as 35.5% and 22% in the RdRp and the capsid
regions, respectively, conﬁrming that they belong to
diﬀerent genera (Figure 2b,c). Finally, when analysing
publicly available sequence databases from a recent
study that investigated the plasma virome of febrile
adult Kenyans [22], and thus has absolutely no link
with our investigations, we identiﬁed 2’290 DicV
reads covering 96.1% (5’350 nt) of ORF1 and 97.5%
(2’525 nt) of ORF2 in one pool (SRR4255933). For
ORF1, the covered sequence showed 95.4–96.4%
nucleotide identity and 98.9–99.2% amino acid identity
compared to the Tanzanian DicV sequences. ORF2 had
similar results, with 91.5–97.5% nucleotide identity and
94.5–99.2% amino acid identities. The phylogenetic
tree of the RdRp region shows that the Kenyan
sequence clusters with the Tanzanian ones (Figure
2b), which represents an additional argument for the
presence of this DicV novel genus in this geographic
region.
Of note, specimens with as few as 6 DicV-speciﬁc
reads could be conﬁrmed by real-time RT–PCR,
whereas 8 with a limited number of reads (≤ 240,
median = 16) could not be conﬁrmed. This latter result
could be explained either by a higher sensitivity of the
HTS in speciﬁc situations (particularly in relation to
the additional freeze–thaw cycle for the real-time
RT–PCR) and/or by the presence of primer-probe mis-
matches (this hypothesis could not be checked since
only a very limited number of reads were obtained).
The number of reads obtained through HTS provides
a rough estimate of the viral load and depends on var-
ious factors, such as cellularity, the presence of other
microorganisms and the eﬃciency of the library prep-
aration [23].
Since dicistroviruses have been observed in a large
spectrum of arthropods worldwide, one hypothesis
raised by our ﬁndings is whether DicV could represent
a viral agent or reﬂects a viral RNA transmission
through contact with vector that still has to be discov-
ered. Indeed, the seasonality clustering observed in this
study, may suggest vector-borne transmission although
others transmission routes cannot be ruled out. A zoo-
notic reservoir is also possible since DicVs have been
detected in stools from various non-human primates
(such as gorillas [24]) as well as giant pandas [25],
and bats [26], which also raises the possibility of a fae-
cal-oral or sylvatic transmission cycle. Furthermore,
the presence of DicV sequences were recently reported
in the blood of a fruit bat captured in 2015 from the
Republic of Congo [27]. In humans, unbiased sequen-
cing analysis of stool samples collected from 35 South
Asian children presenting with non-polio acute
ﬂaccid paralysis revealed the presence of DicV in 3 sub-
jects coinfected with other viruses [28]. Another study
reported DicV sequences in stool samples from
Australian children with acute diarrhoea [29]. In
both studies, whether the presence of DicV in these
stools resulted from a viral replication in the human
gastrointestinal tract or from environmental contami-
nation was not determined. At the in vitro level, the
cellular tropism of DicV has been investigated using
the Taura syndrome virus (TSV): a DicV that infects
shrimp. Exposing various primate cells to this virus
revealed a range of susceptibilities, where RD, Hep-
2C and BGM cells were considered vulnerable to infec-
tion [30], while FRhK-4, MA-104 and BGMK
remained non-permissive [31]. Both animal models
as well as reverse genetics approaches will be needed
to further investigate the tropism and likely replication
sites of DicV in humans.
The present cohort oﬀered the unique opportunity
to assess demographics, symptoms and signs associated
with the presence of DicV RNA. At this time, compara-
tive analysis between DicV-positive and negative
patients (HTS analysis) did not reveal any signiﬁcant
clinical diﬀerences, although the positive patients
were signiﬁcantly younger. The presence of DicV was
not associated with any other co-infections (such as
malaria, HIV or skin infections) nor was it linked to
any other comorbidities. However, our cohort speciﬁ-
cally enrolled patients at the outpatient level who pre-
sented unspeciﬁc febrile illnesses and thus covered a
homogenous spectrum of clinical syndromes from
which to draw conclusions. In the future, larger and
more diverse cohorts should be screened, including
more severe hospitalized children and asymptomatic
blood donors.
In contrast to the paediatric population, DicV RNA
was infrequently detected in adults. Whether this
ﬁnding reﬂects acquired protective immunity in adults,
a more frequent transmission from the vector, a greater
susceptibility in the paediatric population or as men-
tioned above a temporal bias needs to be evaluated. A
recent study investigated the seroprevalence of anti-
bodies against another DicV from another genus
named Triatoma virus (TrV) [32]. TrV is known to
infect the vector responsible for Chagas disease trans-
mission. Their ﬁndings revealed a high prevalence of
anti-TrV antibodies against the TrV structural proteins
in human sera of subjects living in Argentina, Bolivia
and Mexico and suggested a passive transmission of
the virus (i.e. absence of viral replication in human
hosts). To fully investigate the possible transmission
of DicV, future serological investigations should be car-
ried out on a more diverse collection of symptomatic
and asymptomatic adult and paediatric cohorts from
varied geographical regions inside. At this time, we
may raise the hypothesis of a vector-borne trans-
mission and that, among the potential vectors, triato-
mines should be considered.
While this study does not establish the pathogen-
icity or even a true human infection, our ﬁndings
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suggest that DicV could represent a novel agent to con-
sider in humans. We lack an afebrile cohort to assess
the association. Other than the small increase in the
inﬂammatory marker, PCT, we could not identify
any speciﬁc clinical features, diagnoses or co-morbid-
ities associated to DicV infection despite the detailed
clinical database gathered at the time of sample collec-
tion. Elevated PCT is commonly associated (although
not strongly) with bacterial infections; it may be
increased either directly by bacterial endotoxins and
lipopolysaccharides or indirectly by inﬂammatory
mediators (such as tumour necrosis factor-alpha, inter-
leukin-6, interleukin-1). Mediators of viral infection
(interferon-gamma) are thought to attenuate PCT
levels. Thus, its increase in DicV+ patients could be
an indication that DicV may have a pathological
immunomodulatory eﬀect on its human host or an as
yet unidentiﬁed association to another bacterial infec-
tion. However, given the small size eﬀect size, no clini-
cally relevant conclusions could be drawn from this
observation. Notably, the de novo analysis performed
on all sera and plasma specimens (from the paediatric
and adult cohorts respectively) revealed the presence
RNA sequences from viruses known to infect humans
(Supplementary Figure S1). Of the 103 paediatric
patients who were DicV+ by HTS, only ten presented
a co-detection with sequences from these known
human RNA viruses (two human pegivirus-1, two
enteroviruses, four rhinoviruses and two rotaviruses).
Human pegivirus-1 sequences were also detected in
the plasma of the unique DicV+ adult patient by
HTS. Studies in larger and more clinically diverse
patients (including asymptomatic subjects) are needed
to clarify whether DicV is pathogenic or if it should
rather be considered as a member of the commensal
blood virome, similarly to torque tenovirus or human
pegivirus. Screening other types of samples will also
help to deﬁne the in vivo tropism of DicV.
In conclusion, our ﬁndings that DicV RNA is fre-
quently detected in the blood of Tanzanian children
deserve attention. This study provides the ﬁrst step
toward a possible new agent in human, although with-
out proven viral replication and open the door to
further investigation to conﬁrm and contextualize
these results by screening other populations, and fulﬁll-
ing all or part of Koch’s postulates.
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